BRAF and skin cancer: <b>Conclusions</b>: These findings suggest that <i>Cannabis sativa</i> phytoconstituents may represent a promising source of multitarget modulators capable of attenuating EGFR, BRAF V600E, and TGF-β driven oncogenic signaling in skin cancer.